Blueprint Genetics Comprehensive Hereditary Cancer Panel
160-gene germline panel for inherited cancer susceptibility, including selected non-coding variants.
- Developer
- Blueprint Genetics
- Intended use
- Hereditary Cancer
- Cancer scope
- Hematologic neoplasms, Solid tumors
- Specimen
- Saliva, Whole blood
- Molecular modality
- DNA mutation
- Current version
- Current Comprehensive Hereditary Cancer Panel ON1001 (2026-09)
- Evidence context
- 0 structured studies · 0 indexed performance results · 1 sources
Why can reported performance numbers differ? MDI keeps each result attached to its study, population, stage or stratum, test version and source rather than treating performance as a fixed property of the test.